^
12ms
Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors (clinicaltrials.gov)
P1, N=66, Recruiting, Shanghai Best-Link Bioscience, LLC | Not yet recruiting --> Recruiting
Enrollment open
|
BL0020
1year
Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors (clinicaltrials.gov)
P1, N=66, Not yet recruiting, Shanghai Best-Link Bioscience, LLC | Initiation date: Jul 2023 --> Oct 2023
Trial initiation date • Metastases
|
BL0020
over1year
New P1 trial • Metastases
|
BL0020